Re: Christan Walter, Bilal Al-Nawas, Knut A. Grötz, et al. Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate. Eur Urol 2008;54:1066–72

2009 ◽  
Vol 55 (3) ◽  
pp. e61-e62 ◽  
Author(s):  
Alfredo Berruti ◽  
Cinzia Ortega ◽  
Vittorio Fusco
2008 ◽  
Vol 54 (5) ◽  
pp. 1066-1072 ◽  
Author(s):  
Christian Walter ◽  
Bilal Al-Nawas ◽  
Knut A. Grötz ◽  
Christian Thomas ◽  
Joachim W. Thüroff ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 70-71
Author(s):  
Fernando P. Secin ◽  
Clément-Claude Abbou ◽  
Inderbir S. Gill ◽  
Georges Fournier ◽  
Thierry Piéchaud ◽  
...  

Author(s):  
Kathryn M. Wilson ◽  
Lorelei Mucci

Prostate cancer is among the most commonly diagnosed cancers among men, ranking second in cancer globally and first in Western countries. There are marked variations in incidence globally, and its incidence must be interpreted in the context of diagnostic intensity and screening. The uptake of prostate-specific antigen screening since the 1990s has led to dramatic increases in incidence in many countries, resulting in an increased proportion of indolent cancers that would never have come to light clinically in the absence of screening. Risk factors differ when studying prostate cancer overall versus advanced disease. Older age, African ancestry, and family history are established risk factors for prostate cancer. Obesity and smoking are not associated with risk overall, but are associated with increased risk of advanced prostate cancer. Several additional lifestyle factors, medications, and dietary factors are now emerging as risk factors for advanced disease.


2021 ◽  
Vol 32 ◽  
pp. S315
Author(s):  
Billy Susanto ◽  
Griffin Geraldo ◽  
Jennifer Jesse Limanto ◽  
Andree Kurniawan

2010 ◽  
Vol 1 (4) ◽  
pp. 635-639 ◽  
Author(s):  
YOSHIAKI YAMADA ◽  
KATSUYA NARUSE ◽  
KOGENTA NAKAMURA ◽  
TOMOHIRO TAKI ◽  
MOTOI TOBIUME ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document